Remove Documentation Remove Packaging Remove Workshop
article thumbnail

Pre-Filled Syringes East Coast 2022

pharmaphorum

Main Conference: April 25 – 26, 2022 | Workshops: April 27, 2022. Primary Packaging material designers. Secondary packagers. POST CONFERENCE WORKSHOP A: EU MDR 2017/745 Article 117 Requirements. Workshop Leader: Theresa Jeary, Technical Specialist & Scheme Manager, BSi. SMi’s 9th Annual Conference.

article thumbnail

The Aseptic Evolution from Manual Operations to Fully Automated Robotics Solutions

ISPE

This can be found seven times in the entire document. aseptic processing line, filling zone, stopper bowl, open primary packaging or for making aseptic connections under the protection of first air).". Plenty of time for discussion, networking, and interactive workshops in smaller groups.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Piloting the PQA Specialty Pharmacy Turnaround Time Quality Measure

PQA

These concepts were then further evaluated during a workshop with specialty pharmacy stakeholders, during which turnaround time emerged as a high priority for measure development. Pilot participants were provided a technical package containing all resources needed to accurately calculate the SP-TAT-PH measure.

article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

4 , 5 Additionally, reducing shipping limitations—such as packaging, storage, and transportation durations—helps speed up patient access in certain instances while ensuring there is no negative impact to the product’s critical quality attributes (CQAs). These new operating models can help enable and accelerate the efforts of Pharma 4.0™

article thumbnail

Assumptions to evidence: How NINR project is solidifying UK’s remote trial know how

pharmaphorum

Through a series of workshops and surveys, which collected the views of research professionals, patients and carers, the group has developed a new guidance document. But how do we package that up?” But we need to evaluate for the gains we hope for, as well as for any unintended consequences.”. A practical consensus.

article thumbnail

FDA Issues “Cliffs Notes”-style Guidance on Cell and Gene Therapy; What Questions Did They Answer? (Part 1)

The FDA Law Blog

As much of the content of this draft guidance for cellular and gene therapy (CGT) products is articulated elsewhere, this document serves as a one-stop shop or Cliffs Notes for the numerous guidance documents now covering CGT product development. CBER will not commit to reviewing packages greater than 250 pages.

FDA 59